RT Journal Article
SR Electronic
T1 A cohort of patients with COVID-19 in a major teaching hospital in Europe
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.29.20080853
DO 10.1101/2020.04.29.20080853
A1 Borobia, Alberto M.
A1 Carcas, Antonio J.
A1 Arnalich, Francisco
A1 Álvarez-Sala, Rodolfo
A1 Montserrat, Jaime
A1 Quintana, Manuel
A1 Figueira, Juan Carlos
A1 Santos-Olmo, Rosario M. Torres
A1 García-Rodríguez, Julio
A1 Martín-Vega, Alberto
A1 Buño, Antonio
A1 Ramírez, Elena
A1 Martínez-Alés, Gonzalo
A1 Les, Nicolás García-Arenzana
A1 Núñez, M. Concepción
A1 Martí-de-Gracia, Milagros
A1 Ramos, Francisco Moreno
A1 Reinoso-Barbero, Francisco
A1 Martin-Quiros, Alejandro
A1 Núñez, Angélica Rivera
A1 Mingorance, Jesús
A1 Segura, Carlos J Carpio
A1 Arribas, Daniel Prieto
A1 Cuevas, Esther Rey
A1 Sánchez, Concepción Prados
A1 Rios, Juan J.
A1 Hernán, Miguel A.
A1 Frías, Jesús
A1 Arribas, José R
A1 for the COVID@HULP Working Group
YR 2020
UL http://medrxiv.org/content/early/2020/05/06/2020.04.29.20080853.abstract
AB BACKGROUND Since the confirmation of the first patient infected with SARS-CoV-2 in Spain in January 2020, the epidemic has grown rapidly, with the greatest impact on the Madrid region. This article describes the first 2226 consecutive adult patients with COVID-19 admitted to the La Paz University Hospital in Madrid.METHODS Our cohort included all consecutively admitted patients who were hospitalized and who had a final outcome (death or discharge) in a 1286-bed hospital of Madrid (Spain) from February 25th (first case admitted) to April 19th, 2020. Data was entered manually into an electronic case report form, which was monitored prior to the analysis.RESULTS We consecutively included 2226 adult patients admitted to the hospital who either died (460) or were discharged (1766). The patients’ median age was 61 years; 51.8% were women. The most common comorbidity was arterial hypertension (41.3%). The most common symptom on admission were fever (71.2%). The median time from disease onset to hospital admission was 6 days. Overall mortality was 20.7% and was higher in men (26.6% vs 15.1%). Seventy-five patients with a final outcome were transferred to the ICU (3.4%). Most patients admitted to the ICU were men, and the median age was 64 years. Baseline laboratory values on admission were consistent with an impaired immune-inflammatory profile.CONCLUSIONS We provide a description of the first large cohort of hospitalized patients with COVID-19 in Europe. Advanced age, male gender, the presence of comorbidities and abnormal laboratory values were more common among the patients with fatal outcomes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNA